Literature DB >> 9288045

Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project.

M C Raviglione1, C Dye, S Schmidt, A Kochi.   

Abstract

BACKGROUND: Because worldwide tuberculosis (TB) control had never been assessed, WHO set up a surveillance and monitoring project in 1995. The objectives were to assess the performance of national TB programmes; to assess the extent of implementation of the WHO strategy of TB control; and to attempt a comparison between regions that had adopted the WHO strategy and those that had not.
METHODS: In June, 1996, we sent data-collection forms requesting information on national TB programmes' control policies, 1995 case notifications, and 1994 treatment results to 216 countries, areas, and territories. We assessed the performance of national TB programmes by comparing case notifications with estimated incidence and by outcome of treatment in cohorts of patients. We also investigated worldwide treatment success and case detection among sputum-smear-positive patients.
FINDINGS: 180 (83%) of the 216 countries, areas, and territories surveyed replied to WHO (98% of the worldwide population). In 1995, the WHO control strategy had been implemented in 75 countries, and in 39 of these implementation was countrywide. UP to 23% of the worldwide population lived in regions where the strategy was available. In 1995, 3 297 688 cases of TB (all types) were reported, of which 1161411 (35%) were sputum-smear positive. 54% of all reported cases in countries that used the WHO strategy were sputum-smear positive, compared with 30% in other countries. The worldwide case-detection rate of new sputum-smear-positive cases was 35%. 92% of cases registered for treatment in 1994 in regions that used WHO strategy were assessed for outcome and 76% were treated successfully, compared with 54% and 42%, respectively, in regions that had not implemented the WHO strategy. Among cases reported worldwide in 1994, the documented treatment-success rate was 43%.
INTERPRETATION: National TB programmes that have adopted the WHO TB control strategy achieve higher cure rates, but their impact on TB is modest on a worldwide scale. Wider continuous coverage with the WHO strategy is needed for effective worldwide TB control.

Entities:  

Mesh:

Year:  1997        PMID: 9288045     DOI: 10.1016/s0140-6736(97)04146-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Drug-resistant tuberculosis.

Authors:  P D Davies
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

3.  Asking "how?" rather than "what, why, where, and who?".

Authors:  M Chopra; D Sanders
Journal:  BMJ       Date:  2000-09-30

4.  The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling.

Authors:  Si Guo; Lang Bao; Zi Fang Qin; Xin Xin Shi
Journal:  Med Microbiol Immunol       Date:  2010-03-16       Impact factor: 3.402

Review 5.  Should interventions to reduce respirable pollutants be linked to tuberculosis control programmes?

Authors:  Enis Baris; Majid Ezzati
Journal:  BMJ       Date:  2004-11-06

6.  Comparison of the conventional culture, the manual fluorescent MGIT system and the automated fluorescent MGIT 960 culture system for the detection of Mycobacterium avium ssp. avium in tissues of naturally infected hens.

Authors:  E J Shitaye; V Beran; J Svobodová; M Morávková; V Babák; I Pavlík
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

7.  Two Years of Retrospective Study on the Incidence of Tuberculosis in Dir Lower Valley, Khyber Pakhtunkhwa, Pakistan.

Authors:  Shahab Uddin; Faiz Ullah Khan; Tariq Ahmad; Muhammad Maqsood Ur Rehman; Muhammad Arif
Journal:  Hosp Pharm       Date:  2018-02-12

8.  Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis.

Authors:  F A Drobniewski
Journal:  BMJ       Date:  1998-11-07

9.  The tuberculosis epidemic. Scientific challenges and opportunities.

Authors:  A M Ginsberg
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

10.  Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru.

Authors:  F F Willingham; T L Schmitz; M Contreras; S E Kalangi; A M Vivar; L Caviedes; E Schiantarelli; P M Neumann; C Bern; R H Gilman
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.